Patents by Inventor Ana Adela RAMÍREZ BOSCÁ

Ana Adela RAMÍREZ BOSCÁ has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • USE OF PROBIOTICS IN THE TREATMENT AND/OR PREVENTION OF ATOPIC DERMATITIS
    Publication number: 20230048705
    Abstract: The present invention is intended for the use of a probiotic composition comprising Bifidobacterium animalis subs. lactis (B. lactis), Bifidobacterium longum and Lactobacillus casei, particularly the strains B. lactis CECT 8145, B. longum CECT 7347 and/or L. casei CECT 9104, in the treatment and/or prevention of atopic dermatitis.
    Type: Application
    Filed: August 15, 2022
    Publication date: February 16, 2023
    Inventors: Vicente Manuel NAVARRO LÓPEZ, Ana Adela RAMÍREZ BOSCÁ, José Manuel PÉREZ ORQUÍN, Daniel RAMÓN VIDAL, Salvador GENOVÉS MARTÍNEZ, María Empar CHENOLL CUADROS, Francisco Manuel CODOÑER CORTÉS
  • Use of probiotics in the treatment and/or prevention of psoriasis
    Patent number: 10912802
    Abstract: The present invention is intended for the use of a probiotic composition comprising Bifidobacterium animalis subs. lactis (B. lactis), Bifidobacterium longum and Lactobacillus rhamnosus, in particular the strains B. lactis CECT 8145, B. longum ES1 CECT 7347 and/or L. rhamnosus CECT 8361, in the treatment and/or prevention of psoriasis outbreaks or psoriasis.
    Type: Grant
    Filed: March 21, 2017
    Date of Patent: February 9, 2021
    Assignees: Bionou Research, S.L., KOROTT, S.L., BIOPOLIS, S.L.
    Inventors: Vicente Manuel Navarro López, Ana Adela Ramírez Boscá, José Manuel Pérez Orquín, Daniel Ramón Vidal, Salvador Genovés Martínez, María Empar Chenoll Cuadros, Francisco Manuel Codoñer Cortés
  • USE OF PROBIOTICS IN THE TREATMENT AND/OR PREVENTION OF PSORIASIS
    Publication number: 20190328799
    Abstract: The present invention is intended for the use of a probiotic composition comprising Bifidobacterium animalis subs. lactis (B. lactis), Bifidobacterium longum and Lactobacillus rhamnosus, in particular the strains B. lactis CECT 8145, B. longum ES1 CECT 7347 and/or L. rhamnosus CECT 8361, in the treatment and/or prevention of psoriasis outbreaks or psoriasis.
    Type: Application
    Filed: March 21, 2017
    Publication date: October 31, 2019
    Inventors: Vicente Manuel NAVARRO LÓPEZ, Ana Adela RAMÍREZ BOSCÁ, José Manuel PÉREZ ORQUÍN, Daniel RAMÓN VIDAL, Salvador GENOVÉS MARTÍNEZ, MarÍa Empar CHENOLL CUADROS, Francisco CODOÑER CORTÉS
  • USE OF PROBIOTICS IN THE TREATMENT AND/OR PREVENTION OF ATOPIC DERMATITIS
    Publication number: 20190282636
    Abstract: The present invention is intended for the use of a probiotic composition comprising Bifidobacterium animalis subs. lactis (B. lactis), Bifidobacterium longum and Lactobacillus casei, particularly the strains B. lactis CECT 8145, B. longum CECT 7347 and/or L. casei CECT 9104, in the treatment and/or prevention of atopic dermatitis.
    Type: Application
    Filed: July 18, 2017
    Publication date: September 19, 2019
    Inventors: Vicente Manuel NAVARRO LÓPEZ, Ana Adela RAMÍREZ BOSCÁ, José Manuel PÉREZ ORQUÍN, Daniel RAMÓN VIDAL, Salvador GENOVÉS MARTÍNEZ, Maria Empar CHENOLL CUADROS, Francisco Manuel CODOÑER CORTÉS
  • Method for improving the efficacy of curcuminoids and their analogs
    Patent number: 9211270
    Abstract: The invention relates to a method for increasing the therapeutic efficacy of curcuminoids and analogs. More specifically, the invention relates to a method for increasing the therapeutic efficacy of systemically administered formulations that contain curcuminoids and the equivalent therapeutics thereof. The method is characterized in that together with the administration of the formulation the patient is irradiated with visible, and optionally ultraviolet, radiation during a treatment. The invention also relates to phototherapy devices that emit visible radiation over a surface area greater than 0.2 m2 with an irradiance of more than 2 mW/cm2, the devices being suitable for use in the treatment of proliferative diseases, particularly moderate-to-severe psoriasis or tumor processes.
    Type: Grant
    Filed: May 22, 2014
    Date of Patent: December 15, 2015
    Assignee: ASAC Compañia de Technologia e Invertigación, S.A.
    Inventors: Joaquin Diaz Alperi, Ana Adela Ramirez Bosca, August Bernd
  • Method for Improving the Efficacy of Curcuminoids and Their Analogs
    Publication number: 20140257170
    Abstract: The invention relates to a method for increasing the therapeutic efficacy of curcuminoids and analogs. More specifically, the invention relates to a method for increasing the therapeutic efficacy of systemically administered formulations that contain curcuminoids and the equivalent therapeutics thereof. The method is characterized in that together with the administration of the formulation the patient is irradiated with visible, and optionally ultraviolet, radiation during a treatment. The invention also relates to phototherapy devices that emit visible radiation over a surface area greater than 0.2 m2 with an irradiance of more than 2 mW/cm2, the devices being suitable for use in the treatment of proliferative diseases, particularly moderate-to-severe psoriasis or tumor processes.
    Type: Application
    Filed: May 22, 2014
    Publication date: September 11, 2014
    Applicant: ASAC Compañía de Biotecnología e Investigación, S.A.
    Inventors: Joaquin DIAZ ALPERI, Ana Adela RAMIREZ BOSCA, August BERND
  • Method for improving the therapeutic efficacy of curcuminoids and their analogs
    Patent number: 8748494
    Abstract: The invention relates to a method for increasing the therapeutic efficacy of curcuminoids and analogs. More specifically, the invention relates to a method for increasing the therapeutic efficacy of systemically administered formulations that contain curcuminoids and the equivalent therapeutics thereof. The method is characterized in that together with the administration of the formulation the patient is irradiated with visible, and optionally ultraviolet, radiation during a treatment. The invention also relates to phototherapy devices that emit visible radiation over a surface area greater than 0.2 m2 with an irradiance of more than 2 mW/cm2, the devices being suitable for use in the treatment of proliferative diseases, particularly moderate-to-severe psoriasis or tumor processes.
    Type: Grant
    Filed: June 9, 2010
    Date of Patent: June 10, 2014
    Assignee: ASAC Compñia de Biotecnología e Investigación, S.A.
    Inventors: Joaquin Diaz Alperi, Ana Adela Ramirez Bosca, August Bernd
  • Method for improving the therapeutic efficacy of curcuminoids and their analogs
    Publication number: 20100298444
    Abstract: The invention relates to a method for increasing the therapeutic efficacy of curcuminoids and analogs. More specifically, the invention relates to a method for increasing the therapeutic efficacy of systemically administered formulations that contain curcuminoids and the equivalent therapeutics thereof. The method is characterized in that together with the administration of the formulation the patient is irradiated with visible, and optionally ultraviolet, radiation during a treatment. The invention also relates to phototherapy devices that emit visible radiation over a surface area greater than 0.2 m2 with an irradiance of more than 2 mW/cm2, the devices being suitable for use in the treatment of proliferative diseases, particularly moderate-to-severe psoriasis or tumor processes.
    Type: Application
    Filed: June 9, 2010
    Publication date: November 25, 2010
    Applicant: ASAC Compania de Biotecnologia e Investigacion S.A.
    Inventors: Joaquín DÍAZ ALPERI, Ana Adela RAMÍREZ BOSCÁ, August BERND